United States · FDA National Drug Code directory

Betaine Anhydrous

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71863-115_42c7a42b-6a75-69d3-e063-6294a90acc18
Product NDC
71863-115
Form
POWDER, FOR SOLUTION
Composition / generic term
Betaine Anhydrous
Labeler
Eton Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20220128
Source listing expiry
20261231

Source-listed ingredients

  • BETAINE — 1 g/g

These values do not establish equivalence or a dose recommendation.

Packages

  • 180 g in 1 BOTTLE (71863-115-18) · 71863-115-18

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →